DOT-Gene-Editing-Header


Gene editing is rapidly progressing from being a research/screening tool to one that promises important applications downstream in drug development, cell and gene therapy and bioprocessing. Cambridge Healthtech Institute’s conference on New Frontiers in Gene Editing will bring together experts from all aspects of basic science and clinical research to talk about how and where gene editing can be best applied. What are the different tools that can be used for gene editing, and what are their strengths and limitations? How does the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas system, compare to Transcription Activator-like Effector Nucleases (TALENs), zinc finger nucleases (ZFNs) and other systems and where are they being used? Scientists and clinicians from pharma/biotech as well as from academic and government labs will share their experiences leveraging the utility of gene editing for functional screening, disease modeling, and for creating cell and viral therapies. While the opportunities appear limitless, researchers are still struggling to answer what works best under certain conditions.

Who should attend: Students, Post-Docs, Lab Technicians, Managers, Scientists, Clinicians, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Drug Discovery, Functional Screening, Biomarker Discovery, Translational and Clinical Research, Viral Research, Cell and Gene Therapy and Cell Manufacturing.

Topics will include, but are not limited to:

  • Comparing gene editing tools: CRISPRs, TALENs, ZFNs and more
  • Setting up high-throughput screens
  • Creating relevant cell lines and knock-out models for disease modeling
  • Gene editing in stem cells and in vivo
  • Therapeutic applications
  • Tackling challenges with off-target effects and data analysis
  • Regulatory Landscape
  • Concerns around intellectual property issues

If you are interested in speaking, click here to submit a speaking proposal.

The deadline for submission is March 11, 2015. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Tanuja Koppal, Ph.D.
Conference Director
Cambridge Healthtech Institute
E: tkoppal@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup
Sr. Business Development Manager
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

DOT Hub Icon 

2014 Discovery on Target Brochure  

2014 BROCHURE 

PREMIER SPONSOR 

Cellecta 

VIEW ALL SPONSORS 

VIEW MEDIA PARTNERS 


SPONSORSHIPS & EXHIBITS 

The exhibit hall was sold out in 2014, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2015, contact:

Jon Stroup
Sr. Business Development Manager
781-972-5483
jstroup@healthtech.com 


Westin Boston Waterfront

HOTEL & TRAVEL 

Westin Boston Waterfront
425 Summer Street
Boston, MA 02210
617.426.2000